Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities

Mansoura University Hospital

Status: Unknown

Conditions: Multiple Sclerosis; Sexual Dysfunction

Treatments: Diagnostic Test: MRI brain, visual evoked potential, Cerebrospinal Fluid, Sexual dysfunction measure, Depressive symptoms assessment and Multiple Sclerosis Quality of Life-54(MSQOL-54)

Study type: Observational

Funder types: Other

Identifiers

NCT04157283

Mansoura University Hospital 3

Details and patient eligibility

About

This work aims to:

1. Investigate and correlate Sexual Dysfunction in relapsing-remitting Multiple Sclerosis patients with specific focus on

   1. Specific neurologic deficit.
   2. Depressive symptoms.
   3. Comorbid factors.
   4. Fatigue symptoms.

2. To investigate the impact of Sexual dysfunction on Sexual Quality of Life (SQoL).

3. To search for possible gender difference.

Full description

The present study is a cross sectional study on 120 MS adolescent patients meeting the McDonald's criteria; 60 male cases and 60 female cases recruited from Mansoura University Hospitals, Egypt.

All patients were subjected to the following:

1. Clinical Evaluation:

   1. Thorough neurological examination.
   2. Cognitive functions by Minimental State Examination (MMSE).

   e. Expanded Disability Severity Scale (EDSS).

2. Neurophysiological Evaluation:

   a. Visual Evoked Potential (VEP).

3. Imaging Evaluation:

   a. Conventional MRI.

4. Cerebrospinal Fluid (CSF):

5. Sexual dysfunction measure: through the international index of erectile function (IIEF), female sexual function questionnaire (SFQ) and the sexual Quality of life male and female version (SQoL) (American Psychiatric Association, 1994).

6. Depressive symptoms assessment through The BDI (The Beck Depression Inventory) which is the most common instrument measuring the severity of depression.

7. Fatigue symptoms were evaluated through fatigue subscale of Multiple Sclerosis Quality of Life-54(MSQOL-54).

Enrollment: 120 estimated patients

Sex: All

Ages: 20 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 120 MS adolescent patients meeting the McDonald's criteria; 60 male cases and 60 female cases recruited from Mansoura University Hospitals

Exclusion criteria

The exclusion criteria:

• Active relapse or relapse during 30 day prior to survey due to significant changes in all life activities during this period including sexuality.
• EDSS score equal or higher than 6.5.
• Current pregnancy in female patients.
• Form of the disease other than RRMS.
• Patients with any sort of cognitive impairment preventing them from understanding Questionnaire.
• Poorly controlled concomitant diseases were excluded.
• Patients with past history of any sexual problems prior to the first MS attack.
• UN married Patients.

Trial design

120 participants in 2 patient groups

Group 1

Description:

60 male patients

Treatment:

Diagnostic Test: MRI brain, visual evoked potential, Cerebrospinal Fluid, Sexual dysfunction measure, Depressive symptoms assessment and Multiple Sclerosis Quality of Life-54(MSQOL-54)

Group 2

Description:

60 female patients

Treatment:

Diagnostic Test: MRI brain, visual evoked potential, Cerebrospinal Fluid, Sexual dysfunction measure, Depressive symptoms assessment and Multiple Sclerosis Quality of Life-54(MSQOL-54)